Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene |
| |
Authors: | Lee Jeeyun Sung Chang Ohk Lee Eui J Do In-Gu Kim Hee-Cheol Yoon Seong Hyeon Lee Woo Yong Chun Ho Kyung Kim Kyoung-Mee Park Young Suk |
| |
Institution: | Division of Hematology-Oncology, Departments of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea. |
| |
Abstract: | PurposeGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare group of tumors with a wide spectrum of clinical behavior. However, there are no known clinically relevant biomarkers to predict metastasis.Experimental DesignTo investigate differential gene expression signatures of metastatic vs non-metastatic NETs, we studied cell cycle regulatory genes in 19 metastatic and 22 non-metastatic colorectal NETs by PCR arrays. Immunohistochemistry (IHC) and quantitative real-time RT-PCR were performed to verify the results and another set of 38 GEP-NETs were further studied for validation.ResultsWe first delineated six candidate genes for metastasis including ATM, CCND2, RBL2, CDKN3, CCNB1, and GTSE1. ATM was negatively correlated with metastatic NETs (p<0.001) with more than 2-fold change compared to non-metastatic NETs. Overexpression of ATM protein by IHC was strongly correlated with high ATM mRNA levels and low Ki-67 labeling index. Patients with ATM-negativity by IHC showed significantly decreased overall survival than patients with ATM-positivity (median OS, metastatic vs non-metastatic NETs; 2.7 years vs not reached; p?=?0.003) and 85.7% of metastatic NETs were ATM-negative. In another validation set of GEP-NETs, decreased mRNA of ATM gene was associated with metastasis and remained significant (p?=?0.023).ConclusionsATM down-regulation was strongly associated with metastatic NETs when compared with non-metastatic NETs and ATM may be a potential predictive marker for metastasis as well as a novel target in metastatic GEP-NETs. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|